DK1295870T3 - Suplatasttosilatkrystaller - Google Patents

Suplatasttosilatkrystaller

Info

Publication number
DK1295870T3
DK1295870T3 DK02717168T DK02717168T DK1295870T3 DK 1295870 T3 DK1295870 T3 DK 1295870T3 DK 02717168 T DK02717168 T DK 02717168T DK 02717168 T DK02717168 T DK 02717168T DK 1295870 T3 DK1295870 T3 DK 1295870T3
Authority
DK
Denmark
Prior art keywords
suplatast tosilate
crystal
tosilate crystals
suplatast
tosilate crystal
Prior art date
Application number
DK02717168T
Other languages
Danish (da)
English (en)
Inventor
Takanori Ushio
Hidenori Miura
Keiko Nagai
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK1295870T3 publication Critical patent/DK1295870T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/12—Sulfonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DK02717168T 2001-04-16 2002-04-16 Suplatasttosilatkrystaller DK1295870T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001117165 2001-04-16
PCT/JP2002/003762 WO2002083633A1 (fr) 2001-04-16 2002-04-16 Cristaux de tosilate de suplatast

Publications (1)

Publication Number Publication Date
DK1295870T3 true DK1295870T3 (da) 2008-01-28

Family

ID=18967782

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02717168T DK1295870T3 (da) 2001-04-16 2002-04-16 Suplatasttosilatkrystaller

Country Status (16)

Country Link
US (1) US7138140B2 (zh)
EP (1) EP1295870B1 (zh)
JP (1) JP4015954B2 (zh)
KR (1) KR100535305B1 (zh)
CN (1) CN1205182C (zh)
AT (1) ATE381538T1 (zh)
AU (1) AU2002248036B2 (zh)
CA (1) CA2413087C (zh)
CY (1) CY1107112T1 (zh)
DE (1) DE60224145T2 (zh)
DK (1) DK1295870T3 (zh)
ES (1) ES2298358T3 (zh)
HK (1) HK1059773A1 (zh)
PT (1) PT1295870E (zh)
TW (1) TWI241289B (zh)
WO (1) WO2002083633A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955607B2 (en) * 2004-07-13 2011-06-07 Taiho Pharmaceutical Co., Ltd. Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same
JP4794148B2 (ja) * 2004-09-10 2011-10-19 大鵬薬品工業株式会社 ネフローゼ症候群治療剤
JP4498101B2 (ja) * 2004-11-04 2010-07-07 大鵬薬品工業株式会社 頭痛の予防及び／または治療剤
EP1908467B1 (en) * 2005-06-27 2011-01-05 Juntendo Educational Foundation Agent for treating herpesvirus-derived pain
WO2008078826A1 (ja) * 2006-12-26 2008-07-03 Taiho Pharmaceutical Co., Ltd. 糖尿病性ニューロパチー治療剤
AU2018322756B2 (en) * 2017-08-29 2023-10-19 Conrig Pharma Aps Composition comprising suplatast tosilate
EP3813817A4 (en) * 2018-06-27 2022-08-10 Algernon Pharmaceuticals Inc. USE OF ACTARIT IN THE PROPHYLAXIS OR TREATMENT OF KIDNEY FIBROSIS OR KIDNEY DISEASE
CN110824088B (zh) * 2019-11-26 2022-04-12 重庆柳江医药科技有限公司 利用hplc-ms测定甲磺司特在血浆中含量的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
DE4107857A1 (de) * 1991-03-12 1992-09-17 Thomae Gmbh Dr K Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
TW264385B (zh) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
JP3256376B2 (ja) * 1994-01-27 2002-02-12 大鵬薬品工業株式会社 トシル酸スプラタストの結晶およびその製造方法
JP3563480B2 (ja) 1994-03-10 2004-09-08 大鵬薬品工業株式会社 光学活性体の製造方法、並びに光学活性なスルホニウム化合物
CA2192576A1 (en) * 1995-04-24 1996-10-31 Fuminori Tokumochi Remedy for allergic diseases in the region of the nose
US5965565A (en) * 1996-12-12 1999-10-12 Merck & Co., Inc. Piperidines promote release of growth hormone
JP3634622B2 (ja) 1998-05-01 2005-03-30 大鵬薬品工業株式会社 腎透析に伴うそう痒の治療剤
CN1224384C (zh) * 1998-11-05 2005-10-26 大鹏药品工业株式会社 用于治疗排尿紊乱的治疗药物

Also Published As

Publication number Publication date
TWI241289B (en) 2005-10-11
KR100535305B1 (ko) 2005-12-08
JP4015954B2 (ja) 2007-11-28
CY1107112T1 (el) 2012-10-24
EP1295870A1 (en) 2003-03-26
US7138140B2 (en) 2006-11-21
HK1059773A1 (en) 2004-07-16
CA2413087C (en) 2008-03-11
CN1205182C (zh) 2005-06-08
WO2002083633A1 (fr) 2002-10-24
DE60224145T2 (de) 2008-12-11
PT1295870E (pt) 2008-01-10
ATE381538T1 (de) 2008-01-15
EP1295870A4 (en) 2006-01-18
KR20030029051A (ko) 2003-04-11
CN1461297A (zh) 2003-12-10
JPWO2002083633A1 (ja) 2004-08-05
ES2298358T3 (es) 2008-05-16
US20030149105A1 (en) 2003-08-07
DE60224145D1 (de) 2008-01-31
EP1295870B1 (en) 2007-12-19
AU2002248036B2 (en) 2005-04-21
CA2413087A1 (en) 2002-12-16

Similar Documents

Publication Publication Date Title
CY1107112T1 (el) Κρυσταλλοι τοζιλικου suplatast
EE03127B1 (et) Kristalne magneesiumomeprasool, selle valmistamise protsess, seda sisaldavad ravimpreparaadid ja nende kasutamine
MXPA04003936A (es) Cristal en forma alfa o en forma beta de derivado de acetanilida.
MY138452A (en) Novel process for synthesizing and a novel crystal form of agomelatine as well as pharmaceutical preparations containing these
Beilles et al. Preferential crystallisation and comparative crystal growth study between pure enantiomer and racemic mixture of a chiral molecule: 5-ethyl-5-methylhydantoin
DK1270575T3 (da) Hidtil ukendt krystallinsk form af et pyrrolidylthiocarbapenemderivat
NO20016381D0 (no) Dinukleotidkrystaller
NO20011634L (no) Krystall av diuridintetrafosfat eller salter derav, og fremgangsmåte for fremstilling av samme og fremgangsmåte forfremstilling av nevnte forbindelse
Jayaraman et al. A high-pressure Raman study of KReO4, RbReO4 and CsReO4 to 25 GPa and pressure-induced phase transitions
EP1700851A4 (en) CRYSTALLINE ALKALIC CITALOPRAMDIOL INTERMEDIATE PRODUCT
PT655441E (pt) Modificacao cristalina de (4-ciclopropil-6-metil-pirimidin-2-il)-fenil-amina, processo para a sua preparacao e sua utilizacao como fungicida
HUP9801658A2 (hu) Eljárás az 1. típusú ranitidin hidroklorid előállítására és az ezzel az eljárással előállítható termék
EP1462439A4 (en) NEW STABLE CRYSTALS OF SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
JPS6434927A (en) Method for asymmetric photochemical reaction
HUP0302928A2 (hu) N-Hidroxi-2(S)-metil-5-(etoxi-metoxi)-4(S)-[N-(4-fenoxi-benzoil)-amino]-valeramid új kristályformája, eljárás előállítására és hatóanyagként ezt tartalmazó gyógyszerek
TH50989A (th) รูปผลึกที่ vii ของคาเบอร์โกลีน
Masuda et al. Mesoionic 1, 2, 5-thiadiazolium-4-olates
TH25623A (th) กรรมวิธีเพื่อการเตรียมลอราคาร์เบฟ โมโนไฮโดรต
DE69311751D1 (de) Silbernitrat, hergestellt durch ein kontinuierliches Verdampfungs-Kristallisationsverfahren
ATE328869T1 (de) Stabile kristalle von pyrrolverbindungen
EP1676852A4 (en) PROCESS FOR PRODUCING ACTIVE DIHYDROPYRIDINE PHOSPHONES ESTER
TH37385A (th) สารยับยั้งเมทัลโลโปรติเอสชนิด 1,3-ไดเฮเทอโรไซคลิค